Enterprise multimodal AI platform enabling real-time document intelligence across regulated industries including legal, finance, and healthcare. Raised $22M growth stage in February 2025 led by Sequoia Capital.

Why We Invested: The founding team of three ex-Google AI researchers brought unmatched depth in multimodal model architecture, and their insight that regulated industries represented the highest-value beachhead for document AI was sharp and defensible. At the time of our investment they had 14 enterprise pilot customers and $1.1M ARR within 8 months — an exceptional early signal. Post-Investment: Raised $22M Series A led by Sequoia Capital (Feb 2025); grew to $8.4M ARR and 47 enterprise customers; expanded into EU regulatory compliance verticals; team now 68 people. Round: $5M Seed, June 2024.

Founded: 2023 · HQ: San Francisco, CA · Seed: February 2025

AI-native developer experience platform that accelerates code review cycles by 60% through intelligent context synthesis, automated test generation, and developer-authored documentation.

Why We Invested: Developer experience is one of the highest-ROI categories in enterprise software, and Stackrift's founders had built core tooling at Stripe and GitHub before founding the company — they understood the problem from the inside. Their 60% reduction in code review cycle time was validated by three design partner deployments at seed stage. Post-Investment: Grew to 1,200 active developer teams; $2.8M ARR; partnership with GitLab for native integration; raised $9M Series A (Q4 2025). Round: $5M Seed, January 2025.

Founded: 2023 · HQ: Berlin, Germany · Seed: January 2025

Scientific research acceleration platform leveraging large language models to synthesize literature, generate hypotheses, and automate experimental design for pharmaceutical and biotech researchers.

Why We Invested: Scientific research productivity is dramatically underserved by software, and Cogniterra's co-founders — a Stanford computational biologist and an ex-DeepMind researcher — had the rare combination of domain credibility and AI engineering depth needed to win in pharma. Signed letters of intent from two top-20 pharmaceutical companies before we closed. Post-Investment: Three pharmaceutical partnerships signed (including one Top-5 global pharma); $4.1M ARR; raised $14M Series A (Q3 2025); expanded to 22 research institutions. Round: $5M Seed, October 2024.

Founded: 2022 · HQ: Cambridge, UK · Seed: October 2025

Agentic AI operations platform that autonomously manages complex enterprise workflows across ERP, CRM, and HRIS systems — reducing manual process work by up to 80% for mid-market companies.

Why We Invested: Agentic AI for enterprise operations is a once-in-a-decade workflow automation opportunity, and Flowmatic's founders had spent years building automation tooling at ServiceNow and Salesforce — they understood the enterprise change management problem that most AI startups ignore. Product demonstrated 80% manual process reduction in pilot with 4 mid-market companies. Post-Investment: Deployed in 31 enterprise customers; $3.6M ARR; raised $12M Series A led by Bessemer Venture Partners; team grew from 8 to 44 people. Round: $5M Seed, September 2025.

Founded: 2024 · HQ: Toronto, Canada · Seed: September 2025

Industrial computer vision platform for quality control and predictive maintenance in manufacturing. Currently deployed across 18 production facilities in Germany, Poland, and South Korea.

Why We Invested: Industrial quality control is a $40B global market running on legacy vision systems, and Prismara's computer vision model — trained on over 180M manufacturing defect images — outperformed incumbents by 40% on defect detection accuracy in independent benchmarks. The founders had previously built and sold an industrial IoT company, giving them both technical and commercial credibility. Post-Investment: Deployed across 18 production facilities; reduced customer defect escape rates by 62% on average; raised $11M Series A; expanded to automotive and semiconductor verticals. Round: $5M Seed, July 2025.

Founded: 2022 · HQ: Munich, Germany · Seed: July 2025

Cross-border payment infrastructure for SMEs across Southeast Asia. Processes over $800M in annualized transaction volume with settlement times under 2 hours in 14 currency corridors.

Why We Invested: The SME cross-border payment problem in Southeast Asia represents a multi-billion dollar opportunity that the major remittance players have consistently under-served due to the complexity of local regulatory corridors. Orbitpay's founding team included the former head of payments at GrabPay and a fintech regulatory specialist with relationships across 9 Southeast Asian central banks. Post-Investment: Grew annualized transaction volume from $200M to $800M+; expanded to 14 currency corridors; raised $18M Series A led by Ribbit Capital; processing 4,200+ SME clients monthly. Round: $5M Seed, January 2025.

Founded: 2022 · HQ: Singapore · Seed: January 2025

Embedded lending infrastructure enabling software platforms to offer working capital products to their SME customers without a banking license. Processes $120M+ in monthly credit decisions.

Why We Invested: The embedded lending infrastructure opportunity is enormous — thousands of B2B SaaS platforms have captive SME customer bases but no ability to offer working capital, and Bankable Flow solves the compliance and risk infrastructure problem elegantly. The founding team had previously built credit underwriting models at ING and Klarna. Post-Investment: Processes $120M+ in monthly credit decisions; signed 6 platform partnerships including a top-10 European accounting software; raised $16M Series A; team now 38 people. Round: $5M Seed, May 2025.

Founded: 2023 · HQ: Amsterdam, Netherlands · Seed: May 2025

Automated compliance monitoring platform for financial services firms navigating DORA, MiCA, Basel IV, and AML/KYC requirements across EU and UK jurisdictions. Serving 80+ regulated entities.

Why We Invested: The EU regulatory environment is becoming dramatically more complex — DORA, MiCA, Basel IV, and evolving AML/KYC requirements create enormous compliance burden for financial services firms, and ComplianceAI's automated monitoring approach eliminates most of the manual review work. Founded by ex-regulators from the EBA and FCA. Post-Investment: Serves 80+ regulated entities; achieved SOC 2 Type II and ISO 27001 certification; raised $13M Series A; expanded to cover APAC regulatory frameworks. Round: $5M Seed, June 2025.

Founded: 2022 · HQ: Dublin, Ireland · Seed: June 2025

Clinical workflow automation using LLMs trained on proprietary medical ontologies. Reduces documentation burden on clinicians by 45 minutes per shift. Serving 40+ hospital networks across the US and EU.

Why We Invested: Clinical documentation is the single largest source of physician burnout, and MediThread's LLM-based approach — trained on proprietary medical ontologies rather than generic text — produced dramatically more accurate clinical notes than any comparable product we had seen. The founding team included two practicing hospitalists and a former EPIC engineer. Post-Investment: Deployed across 40+ hospital networks; reduces documentation burden by 45 minutes per shift on average; raised $19M Series A led by GV; 94% customer retention rate after 12 months. Round: $5M Seed, January 2025.

Founded: 2022 · HQ: Boston, MA · Seed: January 2025

Carbon intelligence and scope 3 emissions tracking software for manufacturing supply chains. Currently deployed in 12 countries across Europe and Asia-Pacific, tracking 4M+ supplier data points monthly.

Why We Invested: Scope 3 emissions tracking is becoming a legal requirement for large corporations in the EU and UK, yet the data quality problem in supply chain emissions is deeply technical — GreenPulse's ML-based approach to supplier data enrichment was the most sophisticated we had seen. Founders had previously built supply chain software at SAP and Siemens. Post-Investment: Tracking 4M+ supplier data points monthly; deployed in 12 countries; raised $15M Series A; three FTSE 100 companies signed as customers in 2025. Round: $5M Seed, February 2025.

Founded: 2022 · HQ: Stockholm, Sweden · Seed: February 2025

AI-powered pathology analysis platform that accelerates cancer diagnosis timelines from 5 days to under 4 hours. CE-marked in the EU and in FDA clearance process. Deployed in 8 leading cancer centers.

Why We Invested: Cancer diagnosis latency is one of the most consequential delays in oncology — reducing turnaround from 5 days to 4 hours has direct patient survival implications — and Pathosense's model accuracy at 98.7% on an independent benchmark outperformed all existing FDA-cleared solutions. Founders are co-inventors on 14 patents in computational pathology. Post-Investment: CE-marked in EU; in FDA clearance process; deployed in 8 leading cancer centers; raised $21M Series A; partnership with two top global diagnostics companies. Round: $5M Seed, August 2025.

Founded: 2023 · HQ: Zurich, Switzerland · Seed: August 2025

Grid optimization software for renewable energy operators. Uses real-time AI forecasting to reduce curtailment and maximize revenue across solar, wind, and battery storage assets in deregulated markets.

Why We Invested: Curtailment is the silent killer of renewable energy economics — every MW-hour wasted through poor grid management represents both lost revenue and unnecessary carbon, and GridVector's real-time AI forecasting had demonstrated 23% curtailment reduction in a live pilot with a Texas wind operator. The founders had spent 8 years each in energy trading and grid operations. Post-Investment: Managing 2.4GW of renewable assets; average curtailment reduction of 21% across deployments; raised $14M Series A; expanded to California and ERCOT markets. Round: $5M Seed, November 2025.

Founded: 2023 · HQ: Austin, TX · Seed: November 2025

Zero-trust infrastructure for distributed cloud workloads. Founded by veterans of NSA and CISA, with enterprise deployments protecting critical infrastructure across 8 countries and three NATO member states.

Founded: 2022 · HQ: Washington, DC · Seed: February 2025

Real-time data synchronization middleware for hybrid cloud and on-premise enterprise environments. Eliminates data silos without requiring schema migration. Trusted by 3 Fortune 500 enterprises.

Founded: 2023 · HQ: New York, NY · Seed: December 2025

Skills intelligence platform helping enterprises map internal talent, identify skill gaps, and accelerate internal mobility. Reduces external recruiting spend by 35% in first year of deployment.

Founded: 2023 · HQ: London, UK · Seed: July 2025